Grants and Contributions

• The CIHR HIV/AIDS and STBBI Research Initiative (RI), under the leadership of the CIHR Institute of Infection and Immunity (III), is responsible for funding research on human immunodeficiency virus (HIV), hepatitis B (HBV) and C (HCV), chlamydia, gonorrhea, syphilis, and human papilloma virus (HPV). This funding is provided across all CIHR research themes: biomedical research, clinical research, health services research and social, cultural, environmental and population health research.
• Research that focuses on key populations disproportionately affected by HIV/AIDS and STBBI is highly encouraged.
• In alignment with CIHR's commitment to equity, diversity and inclusion (EDI) in the research system, the RI champions EDI as a means to support excellence in research, training and knowledge mobilization. Therefore, we encourage people from diverse backgrounds, including groups underrepresented in science such as women and racial and ethnic minorities, to apply.
• This priority announcement will prioritize funding for research on HIV and/or STBBI aligned with the CIHR HIV/AIDS Research Initiative: Strategic Plan (2022-2027) in the following research areas:
o Improving health equity by advancing research to understand and address determinants of health, new models of care, or sexual and reproductive health for people living with or at risk of HIV/AIDS and STBBI; or
o Accelerating discovery and innovation by advancing research on innovative technologies for testing and surveillance, interactions among infections and co-morbidities, or design and development of next-generation interventions.
• Should there be no eligible applications relevant to the research areas identified above, applications must be in alignment with the strategic directions of the CIHR HIV/AIDS Research Initiative: Strategic Plan (2022-2027) to be funded.

• The CIHR Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA) will fund applications that are determined relevant to its mandate and research priority areas as described below:
• IMHA mandate areas
o Pain
o Oral Health

CIHR is committed to leverage the power of research to accelerate global health equity for all. The CIHR Framework for Action on Global Health Research 2021-2026 recognizes that CIHR must work globally because today’s most pressing health problems, and many of the most effective strategies to prevent, contain, and address them, are global. In alignment with this Framework, this priority announcement aims to grow global health research capacity and excellence.

Funding will be provided for applications that have a primary focus on global health research (as per CIHR’s definition) and that are relevant to one of the mandates below:
o Centre for Research on Pandemic Preparedness and Health Emergencies
o Institute of Gender and Health
o Institute of Population and Public Health

CIHR is committed to leverage the power of research to accelerate global health equity for all. The CIHR Framework for Action on Global Health Research 2021-2026 recognizes that CIHR must work globally because today’s most pressing health problems, and many of the most effective strategies to prevent, contain, and address them, are global. In alignment with this Framework, this priority announcement aims to grow global health research capacity and excellence.

Funding will be provided for applications that have a primary focus on global health research (as per CIHR’s definition) and that are relevant to one of the mandates below:
o Centre for Research on Pandemic Preparedness and Health Emergencies
o Institute of Gender and Health
o Institute of Population and Public Health

• This award was established to recognize the excellence of cancer research being conducted in Canada. This award will be given annually to the highest-ranking Early Career Researchers in the Project competition that fall within the CIHR Institute of Cancer Research (CIHR-ICR) mandate:
o ICR has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.

• The CIHR Institute of Cancer Research (CIHR-ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.
• This priority announcement (PA) is designed to support research in Cancer Prevention and Early Detection of Cancer within the following areas:
o Research that prevents the onset of cancer (lowers cancer risk) and/or reduces the severity of the disease through early detection when it is at its most treatable.
o Research that creates new knowledge in cancer prevention and screening and/or moves it into practice in the health system, communities, workplaces, and in the daily lives of Canadians.

• The CIHR Institute of Cancer Research (CIHR-ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.
• This priority announcement (PA) is designed to support research on decision making when it comes to policies, programs and practices related to cancer care (including screening and prevention) in the following research areas:
o Health Economics and Health Services Research in Cancer Control

• The CIHR Institute of Genetics (CIHR-IG) will provide funding for applications that are determined to be relevant to its mandate:
o CIHR-IG supports research on the human and model genomes and on all aspects of genetics, basic biochemistry and cell biology related to health and disease, including the translation of knowledge into health policy and practice, and the societal implications of genetic discoveries

The specific objective of this funding opportunity is:

• To provide entry for trainees to the SPA 2024 program to trainees interested in the area of: Ageism in Health Research, Delivery, and Outcomes in Older Adults.

The specific objective of this funding opportunity is:

• To provide entry for trainees to the SPA 2024 program to trainees interested in the area of: Ageism in Health Research, Delivery, and Outcomes in Older Adults.